
Viracta Therapeutics (VIRX)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Viracta Therapeutics (VIRX) Stock
Start investing in Viracta Therapeutics (VIRX)
About Viracta Therapeutics (VIRX)
Market cap | $685.6K |
Today's volume | 30.06K |
Revenue (TTM) | — |
Avg. daily volume | 110.44K |
EBITDA (TTM) | -$46.07M |
Open | $0.02 |
Price / earnings ratio | -0.02x |
Today's range | $0.02 - $0.02 |
Debt / equity | — |
52 week range | $0.01 - $0.65 |
5 year debt / equity | — |
Beta (LTM) | 0.56x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | 0.76x |
Ex-dividend date | — |
Next earnings | May 2, 2025 |
Dividend payable date | — |
Viracta Therapeutics Stock Rating
Viracta Therapeutics Stock News
View all



Frequently Asked Questions (FAQ)
How to buy VIRX stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in VIRX stock
Navigate to the Explore page. Then, type VIRX into the search bar. When you see VIRX stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased VIRX stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Viracta Therapeutics Stock Earnings
The value each VIRX share was expected to gain vs. the value that each VIRX share actually gained.
Viracta Therapeutics (VIRX) reported Q3 2024 earnings per share (EPS) of -$0.27, missing estimates of -$0.24 by 12.50%. In the same quarter last year, Viracta Therapeutics's earnings per share (EPS) was -$0.33. Viracta Therapeutics is expected to release next earnings on 05/02/2025, with an earnings per share (EPS) estimate of -$0.19.